Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human PODXL Antibody (Mab47), FITC

Catalog #:   FHA16811 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, FCM
Accession: O00592
Overview

Catalog No.

FHA16811

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Conjugation

FITC

Target

PCLP1, Podocalyxin-like protein 1, GCTM-2 antigen, Gp200, PODXL, Podocalyxin, PC, PCLP, PCLP-1

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

O00592

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

Mab47

Data Image
References

Quantification of Urine and Plasma Levels of Extracellular Vesicles in a Cohort of Kidney Transplant Recipients and Chronic Kidney Disease Patients., PMID:40332150

Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin., PMID:39867135

APOL1 Modulates Renin-Angiotensin System., PMID:39766282

Development of a Multiplexed LC-MS/MS Assay for the Quantitation of Podocyte Injury Biomarkers Nephrin, Podocalyxin, and Podocin in Human Urine., PMID:39651829

Non-endothelial expression of endomucin in the mouse and human choroid., PMID:39153592

Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma., PMID:39051568

Non-endothelial expression of Endomucin in the mouse and human choroid., PMID:38559191

A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts., PMID:38203331

A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma., PMID:38188285

Visualization of choroidal vasculature in pigmented mouse eyes from experimental models of AMD., PMID:38056552

Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier., PMID:37932749

Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer., PMID:37272843

Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer., PMID:37153742

Antibody-Drug Conjugates Targeting Tumor-Specific Mucin Glycoepitopes., PMID:36472102

Characterization of novel antibodies that recognize sialylated keratan sulfate and lacto-N-fucopentaose I on human induced pluripotent cells: comparison with existing antibodies., PMID:36373215

Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis., PMID:35866051

Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models., PMID:35600398

Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients., PMID:35275973

Effect of Everolimus versus Bone Marrow-Derived Stem Cells on Glomerular Injury in a Rat Model of Glomerulonephritis: A Preventive, Predictive and Personalized Implication., PMID:35008770

Epitope Mapping of a Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (PcMab-60) Using Enzyme-Linked Immunosorbent Assay and Surface Plasmon Resonance., PMID:34678093

Modified Huangqi Chifeng Decoction Attenuates Proteinuria by Reducing Podocyte Injury in a Rat Model of Immunoglobulin a Nephropathy., PMID:34381367

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer., PMID:33972616

Glycan Epitopes on 201B7 Human-Induced Pluripotent Stem Cells Using R-10G and R-17F Marker Antibodies., PMID:33805466

Urinary podocalyxin: Is it a real index of disease activity in egyptian patients lupus nephritis?, PMID:33565431

PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin., PMID:33243933

A cancer-specific anti-podocalyxin monoclonal antibody (60-mG2a-f) exerts antitumor effects in mouse xenograft models of pancreatic carcinoma., PMID:33088928

Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy., PMID:33004982

Monoclonal antibodies specific for podocalyxin expressed on human induced pluripotent stem cells., PMID:32912628

Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy., PMID:32712166

Identification of Cell-Surface Proteins Endocytosed by Human Brain Microvascular Endothelial Cells In Vitro., PMID:32585920

Keratan Sulphate in the Tumour Environment., PMID:32266652

IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy., PMID:31796125

PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment., PMID:31759250

iPSC-Derived Embryoid Bodies as Models of c-Met-Mutated Hereditary Papillary Renal Cell Carcinoma., PMID:31575031

Oriented immobilization of rBC2LCN lectin for highly sensitive detection of human pluripotent stem cells using cell culture supernatants., PMID:31473147

Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus., PMID:31382919

Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?, PMID:31220088

Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients., PMID:31166991

Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics., PMID:30472210

Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis., PMID:30415419

Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2., PMID:30105309

Determination of critical epitope of PcMab-47 against human podocalyxin., PMID:29872738

Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma., PMID:29854293

Urinary podocyte-associated molecules and albuminuria in hypertension., PMID:29677049

Anti-Podocalyxin Monoclonal Antibody 47-mG2a Detects Lung Cancers by Immunohistochemistry., PMID:29649375

47-mG2a: A Mouse IgG2a-Type of PcMab-47 Useful for Detecting Podocalyxin in Esophageal Cancers by Immunohistochemistry., PMID:29630446

Loss of ezrin expression reduced the susceptibility to the glomerular injury in mice., PMID:29540766

High glucose induces podocyte epithelial‑to‑mesenchymal transition by demethylation‑mediated enhancement of MMP9 expression., PMID:29436620

Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells., PMID:29245936

Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells., PMID:28980094

Datasheet
$ 225
Product specifications
50 T 225 100 T 372

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human PODXL Antibody (Mab47), FITC [FHA16811]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only